Drawing for VEDA

USPTO serial 98091038

VEDA

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
OSBORNE, AUDRIANA R
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with VEDA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth Oliner

Elizabeth Oliner CRANDON LAW345 GROVE STREET, 2ND FLOORSAN FRANCISCO, CA 94102United States

Goods and services

ClassDescriptionStatusFirst use
042Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Platform as a service (PAAS) featuring computer software platforms for use in running, managing and analyzing clinical trials, namely, enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for use in managing and participating in clinical research and view data analytics, enabling site data capture, selecting configurable data collection methods with configurable options and configuring a participant-facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring non-downloadable software for use in clinical research analytics, data capture forms, electronic clinical outcome assessments (eCOA), recruitment, and electronic consent; Providing a website featuring non-downloadable software for enabling users to manage and participate in clinical research, view data analytics, enable site data capture, and screen participants for eligibility; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth services, scheduling healthcare or telehealth appointments, or allowing a patient to access personal healthcare information for the provision of healthcare or telehealth servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
May 19, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 25, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 25, 2026LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Dec 30, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 8, 2025AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Nov 8, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 21, 2024LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Jun 29, 2024LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Jun 28, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 28, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2024LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
May 24, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2024DOCKASSIGNED TO EXAMINER—
Aug 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance